| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 08/30/2006 | EP1694799A2 Process for upgrading naphtha |
| 08/30/2006 | EP1694686A1 Kinase inhibitors |
| 08/30/2006 | EP1694683A2 Synthetic process |
| 08/30/2006 | EP1694682A1 7-amino-5-halopyrazolopyrimidines with a fungicidal action |
| 08/30/2006 | EP1694681A1 Pyrazolopyrimidines |
| 08/30/2006 | EP1694680A1 Pyrazolopyrimidines |
| 08/30/2006 | EP1694679A1 Pyrazolopyrimidines as fungicidal active ingredients |
| 08/30/2006 | EP1694678A2 Process for preparing hexahydropyrimido 1,2-a¨azepine-2-carboxylates and related compounds |
| 08/30/2006 | EP1694671A2 Quinoxalines useful as inhibitors of protein kinases |
| 08/30/2006 | EP1694643A1 Carboxamide derivatives |
| 08/30/2006 | EP1694642A2 Mutagenic heterocycles |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694330A2 Vinorelbine derivatives |
| 08/30/2006 | EP1487837B1 An improved process for the production of vasicine |
| 08/30/2006 | EP1487450A4 Process for the preparation of antiviral 7-azaindole derivatives |
| 08/30/2006 | EP1429758A4 Photodynamic porphyrin antimicrobial agents |
| 08/30/2006 | CN1826346A N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 08/30/2006 | CN1826345A Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands |
| 08/30/2006 | CN1826344A (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 08/30/2006 | CN1826343A Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 08/30/2006 | CN1826339A 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/30/2006 | CN1272324C Novel herbicides |
| 08/30/2006 | CN1272316C Benzamides and related inhibitors of factor Xa |
| 08/29/2006 | US7098338 2,3,4,4a-tetrahydro-1H-pyrazino(1,2-a) quinoxalin-5(6H)one derivatives |
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098335 Pyrazolopyrimidine compositions |
| 08/29/2006 | US7098334 Inhibitors of 5'-methylthioadenosine phosphorylase (MTAP) and 5'-methylthioadenosine nucleosidase (MTAN); treating cancer, malaria, bacterial infections; (1S)-1-(9-deazaadenin-9-yl)-1,4,5-trideoxy-1,4-imino-D-ribitol for example |
| 08/29/2006 | US7098333 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 08/29/2006 | US7098211 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7098208 Inhibitors of Akt activity |
| 08/29/2006 | US7098207 Imidazotriazinones and the use thereof |
| 08/29/2006 | US7098204 Hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 08/29/2006 | US7097826 Conjugates of ditetratriethylamine pentacarboxylic acid (DTPA) and bisaminoethanethiol (N2S2); for magnetic resonance (MR) imaging; for tumor visualization and necrosis |
| 08/29/2006 | US7097701 Phthalocyanine compound, ink, inkjet recording method, and image forming method |
| 08/29/2006 | CA2395050C N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl) arylsulfonamide compounds and their use as herbicides |
| 08/29/2006 | CA2201785C New carboxylic acid derivatives, their preparation and their use |
| 08/24/2006 | WO2006089298A2 Pyrimidine-fused diazepine derivatives and indole-fused pteridines |
| 08/24/2006 | WO2006089286A2 Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor compounds useful for the treatment and prevention of pain and screening methods therefor |
| 08/24/2006 | WO2006089122A2 De novo synthesis of bacteriochlorins |
| 08/24/2006 | WO2006088949A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
| 08/24/2006 | WO2006088836A2 Piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088476A2 Carboranylporphyrins and uses thereof |
| 08/24/2006 | WO2006087325A1 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said substances |
| 08/24/2006 | WO2006087306A2 Diazabicyclic aryl derivatives and their use as cholinergic ligands at the nicotinic acetylcholine receptors |
| 08/24/2006 | WO2006087305A1 Novel diazabicyclic aryl derivatives and their medical use |
| 08/24/2006 | WO2006078891A3 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives |
| 08/24/2006 | WO2006026313A3 Cancer treatment method |
| 08/24/2006 | WO2006020561A3 Antibacterial agents |
| 08/24/2006 | WO2006019955A3 Antiviral methods and compositions |
| 08/24/2006 | WO2006017822A3 Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 08/24/2006 | WO2006005063A3 Methods and compositions |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189652 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; reacting nitrogen heterocyclic compound with carbonylation agent selected from phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, cyclization |
| 08/24/2006 | US20060189638 kinase inhibitor; proliferative diseases such as cancer, cancer metastasis, inflammation, arthritis, and diseases characterized by abnormal or inappropriate angiogenesis |
| 08/24/2006 | US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 08/24/2006 | US20060189633 Preparation of amorphous form of indiplon |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189631 Substituted imidazopyrimidines for the prevention and treatment of cancer |
| 08/24/2006 | US20060189630 Mitotic kinesin inhibitors |
| 08/24/2006 | US20060189627 RAF inhibitor compounds and methods |
| 08/24/2006 | US20060189619 3-({4-[2-(4-Tert-butylphenyl)-1h-benzimidazol-4-yl]piperazin-1-yl}methyl)pyrido[2,3-b]]pyrazi ne compounds |
| 08/24/2006 | US20060189618 6-{4-[2-(4-tert-butyl-phenyl)-1H-imidazo[4,5-c]pyridin-4-yl]-piperazin-1-ylmethyl}quinoxaline; controls biosynthesis and release of sex steroids in the gonads; contraceptive; anticarcinogenic agent; prostate, uterine, breast, ovarian cancer, endometriosis, uterine fibroids, primary hirsutism |
| 08/24/2006 | US20060189617 e.g. 2-(4-tert-butyl-phenyl)-7-[4-(1-ethyl-2-methyl-1H-imidazol-4-ylmethyl)-piperazin-1-yl]-3H-imidazo[4,5-b]pyridine; anticarcinogenic agent; prostate cancer, endometriosis, uterine fibroids, uterine cancer, breast cancer, ovarian cancer, testicular cancer, or primary hirsutism |
| 08/24/2006 | US20060189616 2-(4-Tert-Butyl-phenyl)-7-[4-(2-ethyl-5-methyl-3H-imidazol-4-ylmethyl)-piperazin-1-yl]-1H-imidazo[4,5-c]pyridine; oral delivery; bioavailability; luteinizing hormone releasing hormone) receptor antagonists; antifertility agents; hormone inhibitors |
| 08/24/2006 | US20060189615 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 08/24/2006 | US20060189597 Lactam compounds and pharmaceutical use thereof |
| 08/24/2006 | US20060189592 Crystal of 1-methylcarbapenem compound |
| 08/24/2006 | US20060188915 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 08/24/2006 | US20060186376 Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance |
| 08/24/2006 | CA2598489A1 Piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598271A1 Pharmacokinetically improved compounds |
| 08/24/2006 | CA2598270A1 Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds |
| 08/24/2006 | CA2597833A1 Pyrazolopyrimidines |
| 08/24/2006 | CA2596015A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
| 08/24/2006 | CA2567468A1 Carboranylporphyrins and uses thereof |
| 08/23/2006 | EP1692508A1 Membrane-based lateral flow assay devices that utilize phosphorescent detection |
| 08/23/2006 | EP1692140A1 Compositions useful as inhibitors of protein kinases |
| 08/23/2006 | EP1692137A1 Process for the preparation of tubulin inhibitors |
| 08/23/2006 | EP1692136A2 Azepinoindole derivatives as pharmaceutical agents |
| 08/23/2006 | EP1692135A1 A new process for preparation of imipenem |
| 08/23/2006 | EP1692091A2 Process for preparation of substituted amino alcohols |
| 08/23/2006 | EP1692085A2 Inhibition of fgfr3 and treatment of multiple myeloma |
| 08/23/2006 | CN1823074A Process for synthesizing beta-lactamase inhibitor intermediates |
| 08/23/2006 | CN1823069A Process for synthesizing beta-lactamase inhibitor intermediates |
| 08/23/2006 | CN1823068A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/23/2006 | CN1823038A Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 08/23/2006 | CN1821442A Method for forming pattern of organic semiconductor film |
| 08/23/2006 | CN1821249A Crystal-free type Idi prone and its preparing method |
| 08/23/2006 | CN1821248A Process for making carbapenem compounds |
| 08/23/2006 | CN1271071C Substituted (6-2-tolyl)-triazolopyrimidines as fungicides |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/22/2006 | US7094920 reacting oxy nitriles with solutions of inorganic acid in an alcohols, to form carbocyclic oxy esters and isomers, used as chemical intermediates for angiotensin converting enzyme inhibitors |
| 08/22/2006 | US7094901 Useful as a cocatalyst for addition coordination polymerization comprising an anion containing at least two Lewis basic sites which are coordinated to Lewis acids, and further containing a hydroxyl group for support attachment |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094894 Reacting a 5-aminotriazole with phenylmalonates to form dihydroxytriazolpyrimidines, halogenating the intermediate to form a dihalogen compound, reacting dihalogen derivative with an amine compound to form 5-halo-7-aminotriazolopyrimidines |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |